{"id":289702,"date":"2023-04-21T16:02:59","date_gmt":"2023-04-21T21:02:59","guid":{"rendered":"https:\/\/www.liveaction.org\/news\/?p=289702"},"modified":"2023-05-01T14:34:29","modified_gmt":"2023-05-01T19:34:29","slug":"controversy-insurers-covering-telemedicine-abortion-provider","status":"publish","type":"post","link":"https:\/\/archive.liveaction.org\/news\/controversy-insurers-covering-telemedicine-abortion-provider\/","title":{"rendered":"Controversy brews as insurers begin covering telemedicine abortion provider"},"content":{"rendered":"
<\/div>

Since the U.S. Supreme Court\u2019s historic reversal of Roe v. Wade<\/em> last summer, chemical abortions via telemedicine have <\/span>surged<\/span><\/a> a whopping 136%. As part of this trend, several insurers recently began contracting with Hey Jane, a virtual abortion provider with no physical locations, to offer coverage for telemedicine abortions via the abortion pill. The move could have a significant impact on the health and safety of women and the lives of preborn children as more women turn to the abortion pill without full knowledge of its potentially dangerous implications.\u00a0<\/span><\/p>\n

The New York Times <\/span>reported<\/span><\/a> on Tuesday that Hey Jane is now contracting with Anthem Blue Cross Blue Shield of Connecticut, Empire Blue Cross Blue Shield of New York, and Sana. Previously, Hey Jane only accepted Aetna insurance in eight of the nine states where it operates.<\/span><\/p>\n

\"Walgreens<\/a><\/p>\n

Pro-abortion advocates are known to claim that mifepristone, the abortion pill, is a safe drug \u2014 as safe as Tylenol, Penicillin, or Viagra \u2014 but these claims are\u00a0exaggerated<\/a> at\u00a0best<\/a>. Also known as a chemical abortion, the regimen involves taking two drugs over the course of several days. The first drug is mifepristone, which blocks progesterone, depriving the baby of nutrients. The second drug is misoprostol, which induces strong contractions, causing the mother to expel her child\u2019s body.\u00a0<\/span><\/p>\n

A study conducted by the abortion industry itself found an ER and urgent care visit rate of <\/span>6%<\/span><\/a> for chemical abortions. Fortunately, lawmakers are taking note. As Live Action News <\/span>reported<\/span><\/a>, a U.S. district judge recently made waves by suspending the FDA\u2019s approval of mifepristone. The abortion pill was approved by the FDA in 2000 and telemedicine abortion has been <\/span>permitted<\/span><\/a> since 2020. The Fifth Circuit Court of Appeals upheld the suspension and the Supreme Court is currently weighing an appeal. In the meantime, the Supreme Court has temporarily allowed continued consumer access to the abortion pill. A decision is expected on Friday.\u00a0<\/span><\/p>\n